Literature DB >> 11085923

Role of cytosolic phospholipase A2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells.

N Nakatani1, N Uozumi, K Kume, M Murakami, I Kudo, T Shimizu.   

Abstract

Cytosolic phospholipase A(2) (cPLA(2)) plays a critical role in mast-cell-related allergic responses [Uozumi, Kume, Nagase, Nakatani, Ishii, Tashiro, Komagata, Maki, Ikuta, Ouchi et al. (1997) Nature (London) 390, 618-622]. Bone-marrow-derived mast cells from mice lacking cPLA(2) (cPLA(-/-)(2) mice) were used in order to better define the role of cPLA(2) in the maturation and degranulation of such cells. Cross-linking of high-affinity receptors for IgE (FcepsilonRI) on cells from cPLA(-/-)(2) mice led to the release of negligible amounts of arachidonic acid or its metabolites, the cysteinyl leukotrienes and prostaglandin D(2), indicating an essential role for cPLA(2) in the production of these allergic and pro-inflammatory lipid mediators. In addition, the histamine content of the mast cells and its release from the cells were reduced to 60%. While these results are in agreement with a reduced anaphylactic phenotype of cPLA(-/-)(2) mice, the ratios of release of histamine and beta-hexosaminidase were, paradoxically, significantly higher for cells from cPLA(-/-)(2) mice than for those from wild-type mice. Consistently, IgE-induced calcium influx in mast cells was greater and more prolonged in cells from cPLA(-/-)(2) mice than in those from wild-type mice. Thus the loss of cPLA(2) not only diminishes the release of lipid mediators, but also alters degranulation. While the overall effect is still a decrease in the release of mast cell mediators, explaining the in vivo findings, the present study proposes a novel link between cPLA(2) and the degranulation machinery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085923      PMCID: PMC1221461     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

Review 1.  Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes.

Authors:  F Snyder
Journal:  Biochim Biophys Acta       Date:  1995-02-09

2.  Cloning and structural analysis of MMCP-1, MMCP-4 and MMCP-5, three mouse mast cell-specific serine proteases.

Authors:  R Y Huang; T Blom; L Hellman
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

3.  Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain.

Authors:  E A Nalefski; L A Sultzman; D M Martin; R W Kriz; P S Towler; J L Knopf; J D Clark
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

4.  Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7.

Authors:  H P McNeil; D S Reynolds; V Schiller; N Ghildyal; D S Gurley; K F Austen; R L Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

5.  cPLA2 is phosphorylated and activated by MAP kinase.

Authors:  L L Lin; M Wartmann; A Y Lin; J L Knopf; A Seth; R J Davis
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

6.  Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat.

Authors:  W E Serafin; T P Sullivan; G A Conder; A Ebrahimi; P Marcham; S S Johnson; K F Austen; D S Reynolds
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

7.  Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line. Indications of different pathways for release of arachidonic acid and secretory granules.

Authors:  N Hirasawa; F Santini; M A Beaven
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

8.  A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains.

Authors:  B P Kennedy; P Payette; J Mudgett; P Vadas; W Pruzanski; M Kwan; C Tang; D E Rancourt; W A Cromlish
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

9.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

Authors:  M MacPhee; K P Chepenik; R A Liddell; K K Nelson; L D Siracusa; A M Buchberg
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

10.  The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase.

Authors:  M Murakami; K F Austen; J P Arm
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

2.  85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study.

Authors:  M Sokolowska; M Borowiec; A Ptasinska; M Cieslak; J H Shelhamer; M L Kowalski; R Pawliczak
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

3.  Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.

Authors:  Chang Han; Kyu Lim; Lihong Xu; Guiying Li; Tong Wu
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

4.  Analysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)α, not Ca(2+)-independent PLA(2)β, to lipid mobilization in proximal mast cells and distal fibroblasts.

Authors:  Noriko Ueno; Yoshitaka Taketomi; Kei Yamamoto; Tetsuya Hirabayashi; Daisuke Kamei; Yoshihiro Kita; Takao Shimizu; Koei Shinzawa; Yoshihide Tsujimoto; Kazutaka Ikeda; Ryo Taguchi; Makoto Murakami
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 5.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

6.  Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis.

Authors:  Yoshitaka Taketomi; Noriko Ueno; Takumi Kojima; Hiroyasu Sato; Remi Murase; Kei Yamamoto; Satoshi Tanaka; Mariko Sakanaka; Masanori Nakamura; Yasumasa Nishito; Momoko Kawana; Naotomo Kambe; Kazutaka Ikeda; Ryo Taguchi; Satoshi Nakamizo; Kenji Kabashima; Michael H Gelb; Makoto Arita; Takehiko Yokomizo; Motonao Nakamura; Kikuko Watanabe; Hiroyuki Hirai; Masataka Nakamura; Yoshimichi Okayama; Chisei Ra; Kosuke Aritake; Yoshihiro Urade; Kazushi Morimoto; Yukihiko Sugimoto; Takao Shimizu; Shuh Narumiya; Shuntaro Hara; Makoto Murakami
Journal:  Nat Immunol       Date:  2013-04-28       Impact factor: 25.606

7.  Bone marrow-derived cPLA2α contributes to renal fibrosis progression.

Authors:  John R Montford; Allison M B Lehman; Colin D Bauer; Jelena Klawitter; Jost Klawitter; Joanna M Poczobutt; Micah Scobey; Mary Weiser-Evans; Raphael A Nemenoff; Seth B Furgeson
Journal:  J Lipid Res       Date:  2017-12-11       Impact factor: 5.922

8.  Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption.

Authors:  Yoshiyuki Satake; Bruno L Diaz; Barbara Balestrieri; Bing K Lam; Yoshihide Kanaoka; Michael J Grusby; Jonathan P Arm
Journal:  J Biol Chem       Date:  2004-02-04       Impact factor: 5.157

9.  Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase.

Authors:  Jennifer A Mietla; Dayanjan S Wijesinghe; L Alexis Hoeferlin; Michael D Shultz; Ramesh Natarajan; Alpha A Fowler; Charles E Chalfant
Journal:  J Lipid Res       Date:  2013-04-10       Impact factor: 5.922

10.  Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15.

Authors:  Fangming Tang; Zhangguo Chen; Cezary Ciszewski; Mala Setty; Jason Solus; Maria Tretiakova; Ellen Ebert; Jin Han; Anning Lin; Stefano Guandalini; Veronika Groh; Thomas Spies; Peter Green; Bana Jabri
Journal:  J Exp Med       Date:  2009-02-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.